Results 311 to 320 of about 4,287,195 (436)

Dual Charge Transfer Mechanisms in Intimately Bonded S‐scheme Heterojunction Photocatalyst with Expeditious Activity toward Environmental Remediation

open access: yesAdvanced Sustainable Systems, EarlyView.
A novel MBOdCN S‐scheme heterojunction photocatalyst is fabricated using pristine Mg‐Bi2O3 and grayish g‐C3N4, where dynamic dual charge migration paths occur to accelerate exciton dissociation. This composite catalyst realizes high degradation efficiency of up to 99.56% of oxytetracycline (OTC) removal under optimized conditions. The material exhibits
Potlako J. Mafa   +11 more
wiley   +1 more source

Reframing Child Protection in Emergency Medicine. [PDF]

open access: yesWest J Emerg Med
Shapiro JP, Preer G, Kistin CJ.
europepmc   +1 more source

A Case of Creutzfeldt-Jakob Disease Presenting With Depression and Anxiety [PDF]

open access: yes, 2019
Barr, Gavin C, Jr. MD   +4 more
core   +1 more source

Innovative Integration of Layered Carbon Materials in Biopolymer Fibrous Membranes for Sustainable Water Treatment

open access: yesAdvanced Sustainable Systems, EarlyView.
This review explores the progressive design of biopolymer‐based fibrous membranes enhanced with layered carbon materials such as MXene, graphene oxide, and carbon nanotubes. It highlights how their integration significantly boosts water filtration performance, selectivity, and antifouling properties.
Sanaz Khademolqorani   +10 more
wiley   +1 more source

Sydenham Chorea: Rare Consequence of Rheumatic Fever. [PDF]

open access: yes, 2014
Glenn-Porter, Bernadette, BS   +3 more
core   +1 more source

On the Relentless Pursuit of an Oral Insulin Delivery System: How Far is Too Far?

open access: yesAdvanced Therapeutics, EarlyView.
Injectable insulin preparations have far outpaced oral ones by virtue of adequate bioavailability and are driven by innovations, including insulin pumps, real‐time blood glucose monitoring, and artificial intelligence. In contrast, oral insulin delivery systems, including nanomedicines, continue to struggle and lag due to varied reasons.
Sourav Bhattacharjee
wiley   +1 more source

Home - About - Disclaimer - Privacy